Vaporox

Denver, United States Founded: 2016 • Age: 10 yrs
Developer of medical device for the wound treatment

About Vaporox

Vaporox is a company based in Denver (United States) founded in 2016. Vaporox has raised $2.25 million across 5 funding rounds from investors including Bioventus, Rockies Venture Club and Innosphere. Vaporox operates in a competitive market with competitors including Natrox, EO2Concepts, Advanced Oxygen Therapy, InotecAMD and Numobag, among others.

  • Headquarter Denver, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website vaporox.com
  • Social LinkedIn
  • Legal Name Vaporox, Inc
Operational Areas
Key Metrics
  • Total Equity Funding
    $2.25M (USD)

    in 5 rounds

  • Latest Funding Round
    $280.13K (USD), Seed

    Jun 2023

  • Investors
    Bioventus

    & 2 more

Funding Insights of Vaporox

Vaporox has successfully raised a total of $2.25M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $280.13 thousand completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.25M
  • Total Rounds 5
  • Last Round Seed β€” $280,129
  • First Round $470,000

    (Apr 2019)

  • Investors Count 3

All 5 funding rounds of Vaporox with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2023$280,129Seed––
–
Jun 2021–Seed––
Mar 2020–Seed–Rockies Venture Club
–
Jan 2020$1.5MSeed–Innosphere
–
Apr 2019$470,000Seed––
–
Valuation history

3 investors in total: 3 institutional.

Investors in Vaporox

Vaporox has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Bioventus, Rockies Venture Club and Innosphere.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Rockies Venture Club is recognized as Colorado’s leading angel investing network.
–rockiesventureclub.orgUnited States
-
–innosphere.org-
Healing therapy products are manufactured for medical applications.
2012bioventus.comDurham, United States
Premium access

Investor details for Vaporox

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Vaporox

10 people are tracked at Vaporox (5 in leadership, 3 in board & advisors, 2 in team).

NameRoleGroup
Alan Sage
CEO & PresidentLeadership
Dustin Kruse
Medical DirectorLeadership
Jennifer Aichele
CFOLeadership
Loren Hutchins
CTOLeadership
Trey Fricke
Vice President Of Sales And MarketingLeadership
Louis Woodhill
Chairperson Of The BoardBoard & advisors
Jon Scott
Operations & Manufacturing AdvisorBoard & advisors
Alex Goldstein
Board MemberBoard & advisors
Genna Gallegos
Office ManagerTeam
Chase Huskey
Senior Marketing ManagerTeam
Premium access

Complete people profiles for Vaporox

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Vaporox

3 dated milestones of Vaporox across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Vaporox is founded.
  2. Funding First funding round of $470K.
  3. Funding Latest funding round, Seed, of $280K.

Competitors of Vaporox

Vaporox operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natrox, EO2Concepts, Advanced Oxygen Therapy, InotecAMD and Numobag, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
natroxwoundcare.com2003Waterbeach, United Kingdom$68.39M31
Oxygen-based wound therapy devices are developed for healing non-healing wounds.
eo2.com2007San Antonio, United States$31.11M19
Continuous oxygen diffusion devices for chronic wound care are developed.
aotinc.net2004Oceanside, United States––
Solutions for treating severe acute and chronic wounds are developed.
inotecamd.com2003Cambridge, United Kingdom–14
Chronic wound solutions are developed via portable oxygen-enrichment devices.
numobag.com2006Northridge, United States$950,000–
Topical hyperbaric oxygen therapy for wound healing is developed.
oz-recovery.com1995Ramat Gan, Israel––
Provides a medical device designed for chronic wound healing.
teknomar.eu1993Ankara, Turkey––
Produces sterilization devices, air sterilizers, and wound care equipment for medical use.
Premium access

Detailed competitors of Vaporox

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Vaporox

The website of Vaporox (vaporox.com) receives about 13.6K visits a month.

  • Monthly visits
    13.6K

    ▲ 472.4% vs previous month

Latest news on Vaporox

Bioventus Invests In Vaporox
Infomeddnews β€’ 5 years ago
Vaporox latest to join Catalyst HTI campus
Innovationews β€’ 7 years ago
Premium access

Complete news archive for Vaporox

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Vaporox

10 companies that operate in the same segment as Vaporox (Wound Care), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanotech-based wound care products are developed and provided.
2010Madison, Wisconsin, United StatesUSD 22.7 M–35
Fish-skin acellular dermal matrix technology is provided for wound treatments.
2007Isafjordur, IcelandUSD 93.11 M–150
Developer of advanced haemostat and wound care dressing products
2008Ahmedabad, Gujarat, IndiaUSD 42.71 MUSD 2.88 M70
Oxygen-based wound therapy devices are developed for healing non-healing wounds.
2003Waterbeach, Cambridgeshire, United KingdomUSD 68.39 M––
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
1985Marietta, Georgia, United States–USD 418.63 M837
Biological drugs for skin and mucosa wound treatment are developed.
2016Uppsala, Uppsala County, SwedenUSD 4.02 MUSD 1.12 M–
Developer of hemostatic products for wound care
2010New York, New York, United StatesUSD 113.35 M––
Regenerative therapies for wound care are developed and commercialized.
1985Canton, Ohio, United StatesUSD 30 MUSD 564.17 M869
Cold plasma solutions for wound treatment are developed.
2013Eindhoven, Noord-brabant, NetherlandsUSD 7.06 M––
Point-of-care devices for wound bacterial assessment are provided.
2013Toronto, Ontario, CanadaUSD 43.2 M–49
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Vaporox

Vaporox was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Vaporox is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.

Alan Sage is the current CEO of Vaporox.

Vaporox is a funded company, having raised a total of $2.25M across 5 funding rounds to date. The company's 1st funding round was a Seed of $470K, raised on Apr 2019.

Provider of clinical-stage veterinary medicine for treating dogs. The company is using patented Vaporous Hyperoxia Therapy (VHT) acts as a delivery system for oxygen, ultrasound waves, and drugs at the site of the wound. The flagship product, VHT-100 is FDA 510(k) cleared device.

Vaporox's top competitors include Natrox, Advanced Oxygen Therapy and EO2Concepts.

Vaporox has 3 investors. Key investors include Bioventus, Rockies Venture Club, and Innosphere.

Vaporox operates through Vaporox, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available